William D. Clark - 17 Apr 2025 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Director
Signature
/s/ William D Clark
Issuer symbol
ALDX
Transactions as of
17 Apr 2025
Net transactions value
$0
Form type
4
Filing time
18 Apr 2025, 16:41:01 UTC
Previous filing
13 Jan 2025
Next filing
24 Nov 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (Right to Buy) Award $0 +76,760 $0.000000 76,760 17 Apr 2025 Common Stock 76,760 $2.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is exercisable in equal annual installments over three years of continuous service to the Issuer after April 17, 2025.